<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CHLORTHALIDONE</span><br/>(klor-thal' i-done)<br/><span class="topboxtradename">Hygroton, </span><span class="topboxtradename">Hylidone, </span><span class="topboxtradename">Novothalidone <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Thalitone, </span><span class="topboxtradename">Uridon <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">electrolyte &amp; water balance agent</span>; <span class="classification">thiazide diuretic</span><br/><b>Prototype: </b>Hydrochlorothiazide<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>15 mg, 25 mg, 50 mg, 100 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Sulfonamide derivative. Differs chemically from thiazides but shares similar actions. Increases excretion of sodium and chloride
         by inhibiting their reabsorption in the cortical diluting segment of the ascending loop of Henle. Reportedly, in some patients,
         it causes elevations in total cholesterol, LDL cholesterol, and triglycerides.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Antihypertensive effect is correlated to the decrease in extracellular and intracellular volumes. Decreased volume results
         in reduced cardiac output with subsequent decrease in peripheral resistance.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Edema associated with CHF, renal decompensation, hepatic cirrhosis, corticosteroid and estrogen therapy; as sole agent or
         with other antihypertensives to treat hypertension.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to sulfonamide derivatives; anuria, hypokalemia; pregnancy (category B), lactation. </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of renal and hepatic disease, gout, SLE, diabetes mellitus.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Hypertension</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 12.525 mg/d, may be increased to 100 mg/d if needed<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 2 mg/kg 3 times/wk<br/><br/><span class="indicationtitle">Edema</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 50100 mg/d, may be increased to 200 mg/d if needed<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Administer as single dose in a.m. to reduce potential for interrupted sleep because of diuresis.</li>
<li>Consult physician when chlorthalidone is used as a diuretic; an intermittent dose schedule may reduce incidence of adverse
            reactions.
         </li>
<li>Store tablets in tightly closed container at 15°30° C (59°86° F) unless otherwise advised.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> CV:</span> Orthostatic hypotension.  <span class="typehead">GI:</span> Anorexia, nausea, vomiting, diarrhea, constipation, cramping, jaundice. <span class="typehead">Hematologic:</span>
<span class="speceff-life">Agranulocytosis</span>, thrombocytopenia, <span class="speceff-life">aplastic anemia</span>. <span class="typehead">CNS:</span> Dizziness, vertigo, paresthesias, headache. <span class="typehead">Metabolic:</span>
<span class="speceff-common">Hypokalemia,</span> hyponatremia, hypochloremia, hypercalcemia, glycosuria, hyperglycemia, exacerbation of gout. <span class="typehead">Skin:</span> Rash, urticaria, photosensitivity, vasculitis. <span class="typehead">Urogenital:</span> Impotence. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  Increased risk of <b>digoxin</b> toxicity because of hypokalemia; <span class="classification">corticosteroids</span>, <b>amphotericin B</b> increases hypokalemia; decreases <b>lithium</b> elimination; may antagonize the hypoglycemic effects of <span class="classification">sulfonylureas</span>; <span class="classification">nsaid</span>s may attenuate diuretic effects; <b>cholestyramine</b> decreases thiazide absorption. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span>  2 h. <span class="typehead"> Peak:</span>  36 h. <span class="typehead"> Duration:</span> 2472 h. <span class="typehead">Distribution:</span> Crosses placenta; appears in breast milk. <span class="typehead">Elimination:</span> 3060% excreted in urine in 24 h. <span class="typehead">Half-Life:</span> 54 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Establish baseline BP measurements and check at regular intervals during period of dosage adjustment when chlorthalidone is
            used for hypertension.
         </li>
<li>Be alert to signs of hypokalemia (see Appendix F). Older adult patients are more sensitive to adverse effects of drug-induced
            diuresis because of age-related changes in the cardiovascular and renal systems.
         </li>
<li>Lab tests: Baseline and periodic: serum electrolytes (particularly K, Mg, Ca), serum uric acid, creatinine, BUN, and uric
            acid and blood glucose (especially in patients with diabetes).
         </li>
<li>Monitor lithium and digoxin levels closely when either of these drugs is used concurrently.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Maintain adequate potassium intake, monitor weight, and make a daily estimate of I&amp;O ratio.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>